Search is Powered by Google
Cervical Cancer / HPV Vaccine News

British MDs Favor Gardasil For Own Children Despite Government Coverage Of Cervarix

Main Category: Cervical Cancer / HPV Vaccine
Also Included In: Primary Care / General Practice
Article Date: 28 Oct 2008 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Many British doctors are choosing Merck's human papillomavirus vaccine Gardasil for their own children over GlaxoSmithKline's Cervarix, which was selected by for coverage through Britain's National Health Service, according to a comment by Phil Hammond, a British doctor and media broadcaster, published Friday in the British Medical Journal, Reuters reports. Gardasil is designed to protect against four strains of HPV, two of which cause cervical cancer, while while Cervarix targets the two cancer-causing strains of HPV.

According to Hammond, doctors he spoke with said they chose Gardasil for their own children because of the vaccine's ability to protect against both cervical cancer and genital warts. Cervarix is still awaiting U.S. approval, but was chosen by Britain for its cervical cancer program because it is less expensive, although the amount the government paid for the vaccine was not disclosed, Reuters reports. However, a recent study estimated that Cervarix's price of 13 to 21 British pounds -- or about $21 to $34 -- less than Gardasil would save up to 19 million pounds, or about $30 million, during the first year of the program.

Hammond writes that people who can afford Gardasil will opt for the more expensive vaccine over Cervarix, creating a two-tiered health system that favors the wealthy. "Outside the program, many doctors will recommend Gardasil because of the extra protection it offers, so we may end up with all women in the program getting Cervarix and most outside of it getting Gardasil," Hammond writes, adding, "This clearly has the potential to undermine the program" (Reuters, 10/24).

An abstract of the article is available online.

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2008 The Advisory Board Company. All rights reserved.

View drug information on Gardasil.





Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
HPV Vaccine Gardasil Under Investigation For Adverse Events, New York Post Reports
09 Jul 2008
Lawyers for two girls who received Merck's human papillomavirus vaccine Gardasil last month filed the first two claims under the federal Vaccine Injury Compensation Program, the...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

Cancer 101 image Cancer 101

What causes cancer and why is it so hard to treat? Leading experts provide an overview of cancer, from what goes wrong in a cell's genetic instructions to the latest treatment strategies...

View more videos...